Pharmacology of the Neurotransmitter Release Enhancer Linopirdine (DuP 996), and Insights into Its Mechanism of Action

This publication has 52 references indexed in Scilit:

• Calcium channel antagonists induce direct inhibition of the outward rectifying potassium channel in tobacco protoplasts
  FEBS Letters, 1994
• Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release
  Neuron, 1993
• Muscarinic receptor-mediated induction of Fos protein in rat brain
  Neuroscience Letters, 1993
• The effect of 3,3,-dipyridylmethyl-1-phenyl-2-indolinone on the neuromuscular transmission in the rodent skeletal muscles
  Neuropharmacology, 1992
• EEG mapping central effects of multiple doses of linopirine—a cognitive enhancer—in healthy elderly male subjects
  Human Psychopharmacology: Clinical and Experimental, 1991
• The effects of 4-aminopyridine and tetraethylammonium on the kinetics of transmitter release at the mammalian neuromuscular synapse
  Canadian Journal of Physiology and Pharmacology, 1989
• Agonists that suppress M-current elicit phosphoinositide turnover and Ca2+ transients, but these events do not explain M-current suppression
  Neuron, 1988
• Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors
  Life Sciences, 1988
• Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
  New England Journal of Medicine, 1986
• Effects of 4-Aminopyridine in Elderly Patients with Alzheimer’s Disease
  New England Journal of Medicine, 1984